573 related articles for article (PubMed ID: 17914087)
21. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.
Untergasser G; Plas E; Pfister G; Heinrich E; Berger P
Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938
[TBL] [Abstract][Full Text] [Related]
22. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
Xie S; Lin HK; Ni J; Yang L; Wang L; di Sant'Agnese PA; Chang C
Prostate; 2004 Jun; 60(1):61-7. PubMed ID: 15129430
[TBL] [Abstract][Full Text] [Related]
23. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
Mosca A; Berruti A; Russo L; Torta M; Dogliotti L
J Endocrinol Invest; 2005; 28(11 Suppl International):141-5. PubMed ID: 16625864
[TBL] [Abstract][Full Text] [Related]
24. Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.
Wu C; Zhang L; Bourne PA; Reeder JE; di Sant'Agnese PA; Yao JL; Na Y; Huang J
Prostate; 2006 Aug; 66(11):1125-35. PubMed ID: 16652382
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine differentiation in the progression of prostate cancer.
Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H
Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524
[TBL] [Abstract][Full Text] [Related]
26. Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.
Kvissel AK; Ramberg H; Eide T; Svindland A; Skålhegg BS; Taskén KA
Cell Signal; 2007 Feb; 19(2):401-9. PubMed ID: 16949795
[TBL] [Abstract][Full Text] [Related]
27. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T
Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of neuroendocrine differentiation in prostate cancer.
Nelson EC; Cambio AJ; Yang JC; Ok JH; Lara PN; Evans CP
Prostate Cancer Prostatic Dis; 2007; 10(1):6-14. PubMed ID: 17075603
[TBL] [Abstract][Full Text] [Related]
29. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine differentiation in human prostatic tumor models.
Noordzij MA; van Weerden WM; de Ridder CM; van der Kwast TH; Schröder FH; van Steenbrugge GJ
Am J Pathol; 1996 Sep; 149(3):859-71. PubMed ID: 8780390
[TBL] [Abstract][Full Text] [Related]
31. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.
Zhang XQ; Kondrikov D; Yuan TC; Lin FF; Hansen J; Lin MF
Oncogene; 2003 Oct; 22(43):6704-16. PubMed ID: 14555984
[TBL] [Abstract][Full Text] [Related]
32. Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.
Deeble PD; Cox ME; Frierson HF; Sikes RA; Palmer JB; Davidson RJ; Casarez EV; Amorino GP; Parsons SJ
Cancer Res; 2007 Apr; 67(8):3663-72. PubMed ID: 17440078
[TBL] [Abstract][Full Text] [Related]
33. [Alterations in ATP-dependence of swelling-activated Cl- current associated with neuroendocrine differentiation of LNCaP human prostate cancer epithelial cells].
Lazarenko RM; Kondrats'kyĭ AP; Pohoriela NKh; Shuba IaM
Fiziol Zh (1994); 2005; 51(3):57-66. PubMed ID: 16108226
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
Wang Q; Horiatis D; Pinski J
Int J Cancer; 2004 Sep; 111(4):508-13. PubMed ID: 15239127
[TBL] [Abstract][Full Text] [Related]
35. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
Matsumoto Y; Mibu H; Kagebayashi Y
Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
[TBL] [Abstract][Full Text] [Related]
36. [Neuroendocrine features of prostatic tumors: state of the art].
Turitto G; Frattolillo A; Iodice P; Auriemma A; Tortoriello A; di Grazia M; Iaffaioli RV
Recenti Prog Med; 2003 Dec; 94(12):568-72. PubMed ID: 14974154
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.
Wright ME; Tsai MJ; Aebersold R
Mol Endocrinol; 2003 Sep; 17(9):1726-37. PubMed ID: 12775765
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
[TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP.
Goodin JL; Rutherford CL
Mol Carcinog; 2002 Feb; 33(2):88-98. PubMed ID: 11813301
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine differentiation in prostatic malignancy.
di Sant'Agnese PA; Cockett AT
Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
